Dan Reed’s blog has an update on presentations from last week’s President’s Council of Science and Technology Advisors (PCAST) meeting. He links to his slides and discusses an excellent slide from Susan Butts at Dow Chemical on the benefits of federally sponsored research.
Dr. Reed closed his post with this paragraph, reflecting on one of the presentations from the medicine subcommittee:
It really make me reflect again that so many things we call cancer, respiratory disease, heart disease or other things are in fact a hugely diverse set of genetic diseases. It also emphasizes the power of computing for good, as personalized medicine, whether for medical records management, genetic sequencing, diagnostics and imaging or biological processor modeling, depends critically on the power for computing and data analysis.